TRCT
ERAS icon

Tower Research Capital (TRC)’s Erasca ERAS Stock Holding History

Tower Research Capital (TRC)’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$133K Sell
7,248
-25,057
-78% -$358K ﹤0.01% 1986
2026
Q1 		$523K Buy
32,305
+25,421
+369% +$300K 0.01% 879
2025
Q4 		$25.6K Sell
6,884
-4,263
-38% -$12K ﹤0.01% 2915
2025
Q3 		$24.3K Sell
11,147
-10,386
-48% -$16.5K ﹤0.01% 3127
2025
Q2 		$27.3K Buy
21,533
+7,351
+52% +$9.84K ﹤0.01% 3474
2025
Q1 		$19.4K Sell
14,182
-9,141
-39% -$15.7K ﹤0.01% 2994
2024
Q4 		$58.5K Buy
23,323
+16,547
+244% +$45.4K ﹤0.01% 2459
2024
Q3 		$18.5K Sell
6,776
-5,873
-46% -$16.5K ﹤0.01% 3279
2024
Q2 		$29.9K Buy
12,649
+9,704
+330% +$20.9K ﹤0.01% 3492
2024
Q1 		$6.07K Sell
2,945
-15,195
-84% -$30.4K ﹤0.01% 4439
2023
Q4 		$38.6K Buy
18,140
+5,711
+46% +$12K ﹤0.01% 3291
2023
Q3 		$24.5K Buy
12,429
+8,705
+234% +$22.3K ﹤0.01% 3195
2023
Q2 		$10.3K Sell
3,724
-7,802
-68% -$22.2K ﹤0.01% 4140
2023
Q1 		$35K Buy
11,526
+10,626
+1,181% +$38.6K ﹤0.01% 2836
2022
Q4 		$4K Sell
900
-4,010
-82% -$27.2K ﹤0.01% 5000
2022
Q3 		$38K Sell
4,910
-1,039
-17% -$8.37K ﹤0.01% 3398
2022
Q2 		$33K Sell
5,949
-1,826
-23% -$12K ﹤0.01% 3272
2022
Q1 		$67K Buy
7,775
+6,040
+348% +$70K ﹤0.01% 2499
2021
Q4 		$27K Buy
1,735
+754
+77% +$12.9K ﹤0.01% 3340
2021
Q3 		$21K Buy
+981
New +$20.2K ﹤0.01% 3662

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Tower Research Capital (TRC)'s ERAS Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Erasca (ERAS) stake by 78% in Q2 2026, selling an estimated $358K and leaving 7,248 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #1986.

Tower Research Capital (TRC) first reported a position in ERAS in Q3 2021 and has held it in 20 quarters since. The position peaked at $523K in Q1 2026. 256 funds tracked by Wall St. Rank hold ERAS as of Q2 2026.

  • Tower Research Capital (TRC) held 7,248 shares of Erasca worth $133K as of Q2 2026.
  • Tower Research Capital (TRC) sold 25,057 Erasca shares in Q2 2026, an estimated $358K.
  • Erasca made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #1986 holding.
  • Tower Research Capital (TRC) first reported a position in Erasca in Q3 2021 and has held it in 20 quarters since.
  • Tower Research Capital (TRC)'s Erasca position peaked at $523K in Q1 2026.
  • 256 funds tracked by Wall St. Rank held Erasca as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.